DK0804234T3 - Adjuvans til vacciner - Google Patents

Adjuvans til vacciner

Info

Publication number
DK0804234T3
DK0804234T3 DK95942006T DK95942006T DK0804234T3 DK 0804234 T3 DK0804234 T3 DK 0804234T3 DK 95942006 T DK95942006 T DK 95942006T DK 95942006 T DK95942006 T DK 95942006T DK 0804234 T3 DK0804234 T3 DK 0804234T3
Authority
DK
Denmark
Prior art keywords
adjuvants
vaccines
repeating units
adjuvant
constitutive repeating
Prior art date
Application number
DK95942006T
Other languages
English (en)
Inventor
Luuk Hilgers
Michel Strebelle
Original Assignee
Dimminaco Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dimminaco Ag filed Critical Dimminaco Ag
Application granted granted Critical
Publication of DK0804234T3 publication Critical patent/DK0804234T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Devices For Use In Laboratory Experiments (AREA)
DK95942006T 1994-12-27 1995-12-21 Adjuvans til vacciner DK0804234T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE9401173A BE1008977A5 (fr) 1994-12-27 1994-12-27 Adjuvants pour vaccins.
PCT/BE1995/000118 WO1996020007A1 (fr) 1994-12-27 1995-12-21 Adjuvants pour vaccins

Publications (1)

Publication Number Publication Date
DK0804234T3 true DK0804234T3 (da) 1999-11-15

Family

ID=3888559

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95942006T DK0804234T3 (da) 1994-12-27 1995-12-21 Adjuvans til vacciner

Country Status (15)

Country Link
US (1) US6340464B1 (da)
EP (1) EP0804234B1 (da)
JP (1) JP3817655B2 (da)
CN (1) CN1087177C (da)
AT (1) ATE180676T1 (da)
AU (1) AU713660B2 (da)
BE (1) BE1008977A5 (da)
BR (1) BR9510286A (da)
CA (1) CA2208860C (da)
DE (1) DE69510089T2 (da)
DK (1) DK0804234T3 (da)
ES (1) ES2131879T3 (da)
GR (1) GR3031103T3 (da)
SI (1) SI0804234T1 (da)
WO (1) WO1996020007A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9622159D0 (en) * 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
FR2776928B1 (fr) * 1998-04-03 2000-06-23 Merial Sas Vaccins adn adjuves
CL2008001806A1 (es) 2007-06-20 2008-09-05 Wyeth Corp Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion.
JP2018020962A (ja) * 2014-12-08 2018-02-08 エヌエーアイ株式会社 新規アジュバント
PT3471760T (pt) 2016-06-17 2025-01-20 Sanofi Pasteur Sa Formulações imunogénicas inovadoras compreendendo adjuvantes de polímero de ácido poliacrílico linear ou ramificado
CN110404064B (zh) * 2018-04-27 2023-06-16 洛阳赛威生物科技有限公司 一种禽用佐剂组合物及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE161050C (da) *
US3790665A (en) * 1968-02-23 1974-02-05 Haver Lockhart Labor Inc Injectable adjuvant,method of preparing same and compositions including such adjuvant
US3790655A (en) * 1971-03-02 1974-02-05 E B & A C Whiting Co Method for commingling and orienting colored sets of thermoplastic filaments
US3920811A (en) * 1972-12-22 1975-11-18 Cutter Lab Adjuvant compositions
US4340726A (en) * 1980-03-14 1982-07-20 Newport Pharmaceuticals International, Inc. Esters
US5047238A (en) * 1983-06-15 1991-09-10 American Home Products Corporation Adjuvants for vaccines
ATE60999T1 (de) * 1986-12-19 1991-03-15 Duphar Int Res Dimethyldioctadecylammoniumbromid enthaltende stabilisierte adjuvanssuspension.
EP0283085B1 (en) * 1987-03-17 1992-11-11 Akzo N.V. Adjuvant mixture
US5565209A (en) * 1987-03-17 1996-10-15 Akzo Nobel N.V. Adjuvant mixture
NZ239643A (en) * 1990-09-17 1996-05-28 North American Vaccine Inc Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group.
US5242686A (en) * 1990-11-07 1993-09-07 American Home Products Corporation Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
CA2085827C (en) * 1991-12-23 2003-10-14 Lucas A. T. Hilgers Adjuvant composition containing synthetic hydrophobic lipopolysaccharide
US5883262A (en) * 1994-04-22 1999-03-16 Sumitomo Chemical Company, Limited Ether compounds and their use

Also Published As

Publication number Publication date
JPH11502191A (ja) 1999-02-23
BE1008977A5 (fr) 1996-10-01
WO1996020007A1 (fr) 1996-07-04
MX9704823A (es) 1998-06-30
GR3031103T3 (en) 1999-12-31
EP0804234B1 (fr) 1999-06-02
DE69510089D1 (en) 1999-07-08
AU713660B2 (en) 1999-12-09
CN1171053A (zh) 1998-01-21
SI0804234T1 (en) 1999-08-31
EP0804234A1 (fr) 1997-11-05
ES2131879T3 (es) 1999-08-01
ATE180676T1 (de) 1999-06-15
DE69510089T2 (de) 1999-09-23
BR9510286A (pt) 1997-11-11
CA2208860C (en) 2009-03-17
AU4324796A (en) 1996-07-19
CN1087177C (zh) 2002-07-10
CA2208860A1 (en) 1996-07-04
JP3817655B2 (ja) 2006-09-06
US6340464B1 (en) 2002-01-22

Similar Documents

Publication Publication Date Title
DE69428795D1 (de) Phosphazene und polyelektrolyte als immunadjuvantien
EP0269926A3 (en) Lens usable in the ultraviolet
NO180668C (no) Kryss-bundede, sårsekretabsorberende hydrogeler
ATA175988A (de) Extraktionsmittel fuer poly-d(-)-3-hydroxybutter- saeure
ATE219686T1 (de) Proteinartige adjuvantien
DE3874619D1 (de) Herstellungsverfahren eines optisch aktiven alkohols.
JPS5296791A (en) Preparation of composition including enzymes or microorganisms
DE59101881D1 (de) Verfahren zur herstellung von polyacrylsäuren.
AU4015493A (en) Process for preparing polysuccinimides from aspartic acid
ATE249841T1 (de) Immunogene zubereitungen
DK0804234T3 (da) Adjuvans til vacciner
DE3874627D1 (de) Herstellungsverfahren eines optisch aktiven alkohols.
HUT77018A (hu) Eljárás terpolimerek előállítására
DK0545199T3 (da) Anvendelse af svampemycelium som jordkonditioneringsmiddel
DE59100224D1 (de) Hoechstdruckplungerpumpe.
CA2037709A1 (en) Use of zinc calcium hydroxide, lecithin and pao as an adjuvant for antigen solutions, and antigen solutions treated with an adjuvant of this type
DK52783D0 (da) Vaccine indeholdende en ozoninaktiveret mikroorganisme og fremgangsmade til fremstilling af en sadan vaccine
JPS545096A (en) Method of immobilizing enzyme or mold using betain polymer
FR2424026A1 (fr) Medicaments a base d'ethers hydrosolubles d'hydroxyflavones pour le traitement des affections decoulant de la fragilite et de la permeabilite des capillaires sanguins
RU96107439A (ru) Способ подготовки мягких контактных линз к применению
JPS5219301A (en) Pressure compensation control system
JPS5419949A (en) Chalcone derivatives
MD259C2 (ro) Metodă de tratament al maladiei ulceroase a duodenului, complicată cu stenoză piloroduodenală
SU1672636A1 (ru) Адъювант для производства противоящурной вакцины
TH5761B (th) วิธีการเตรียมชิ้นกล้าสำหรับการเลี้ยงเนื้อเยื่อพืช